Last Price
16.00
Today's Change
-0.15 (0.92%)
Day's Change
15.87 - 16.43
Trading Volume
39,418
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Roger Crystal M.D. Dr. Roger Crystal M.D.
Full Time Employees: 37 37
IPO Date: 2007-06-04 2007-06-04
CIK: 0001385508 0001385508
ISIN: US6837501039 US6837501039
CUSIP: 683750103 683750103
Beta: 0.83 0.83
Last Dividend: 0.00 0.00
Dcf Diff: 6.05 6.05
Dcf: 26.31 26.31
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.